Trump may be mystery patient in odd case of 79yo getting experimental obesity drug

Public notice of a single "compassionate use" case is odd in every way. In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly's powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration's "compassionate use" program—raising immediate questions